RFK Jr.'s Peptide Push Could Spark $180B Wellness Boom—Here's Who Wins
Robert F. Kennedy Jr.'s campaign to ease federal restrictions on peptides could trigger a massive wellness trend, benefiting telehealth firms, compoun...
Robert F. Kennedy Jr.'s campaign to ease federal restrictions on peptides could trigger a massive wellness trend, benefiting telehealth firms, compoun...
The FDA banned 19 peptide drugs for compounding pharmacies in 2023 due to safety concerns. Now, under HHS Secretary RFK Jr., the agency may reverse th...